 |
Gil Roth
|
 |
Opportunities in uncertain times
Kristin Brooks
|
 |
Strategies for getting to Phase I quicker and saving API
Paul Skultety, Ph.D.
|
 |
A versatile ingredient works in excipient applications
Gerald K. Schalau II and Katherine L. Ulman
|
 |
Aseptic blow/fill/seal vs. traditional aseptic processing
Chuck Reed
|
 |
Innovation, trends and challenges
Kristin Brooks
|
 |
Recent changes in security affect pharma facilities
Evan Wolff, Maida Oringher Lerner, and Matthew Melewski
|
 |
Can e-integration speed drug development?
Robert Barr
|
Magazine
